SCHEMBL7085859

SCHEMBL7085859

COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2O[C@@H]2OC(C)[C@H](O)C(O)[C@@H]2O)ccc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P4HB P07237 5/20 0.85
▸ SYNJ2 O15056 1/20 0.85
▸ EPHX2 P34913 4/20 0.83
▸ KDM4E B2RXH2 4/20 0.83
▸ SLCO2B1 O94956 3/20 0.83
▸ L3MBTL1 Q9Y468 3/20 0.83
▸ MAOA P21397 3/20 0.83
▸ XDH P47989 3/20 0.83
▸ AKR1B1 P15121 2/20 0.83
▸ PIM2 Q9P1W9 2/20 0.83
▸ ALDH1A1 P00352 2/20 0.83
▸ CA12 O43570 1/20 0.83
▸ CA2 P00918 1/20 0.83
▸ CA4 P22748 1/20 0.83
▸ CA7 P43166 1/20 0.83
▸ NQO2 P16083 1/20 0.79
▸ POLB P06746 3/20 0.73
▸ GAA P10253 3/20 0.73
▸ MAPT P10636 3/20 0.73
▸ MPI P34949 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13927008 1.00 P4HB (0.85) P4HBSYNJ2EPHX2KDM4ESLCO2B1
Narcissin SCHEMBL30389758 0.92 P4HB (1.00) P4HBSYNJ2EPHX2KDM4EL3MBTL1
Narcissin SCHEMBL1305421 0.92 P4HB (1.00) P4HBSYNJ2EPHX2KDM4EL3MBTL1
Narcissin SCHEMBL29516911 0.92 P4HB (1.00) P4HBSYNJ2EPHX2KDM4EL3MBTL1
Narcissin SCHEMBL15773535 0.92 P4HB (1.00) P4HBSYNJ2EPHX2KDM4EL3MBTL1
Narcissin SCHEMBL31236364 0.92 P4HB (1.00) P4HBSYNJ2EPHX2KDM4EL3MBTL1
Narcissin SCHEMBL31236367 0.92 P4HB (1.00) P4HBSYNJ2EPHX2KDM4EL3MBTL1
Narcissin SCHEMBL1305418 0.92 P4HB (1.00) P4HBSYNJ2EPHX2KDM4EL3MBTL1
Narcissin SCHEMBL7167500 0.92 P4HB (1.00) P4HBSYNJ2EPHX2KDM4EL3MBTL1
Quercitrin SCHEMBL5456136 0.91 P4HB (1.00) P4HBEPHX2KDM4ESLCO2B1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030072824-A1 Ume extract having medicinal effects and compositions containing the same TERUAKI HAYASHI (JP) 2003-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030072824-A1 Ume extract having medicinal effects and compositions containing the same GALE, UGDH, UGGT1 P4HB 4285/4885SYNJ2 3831/4885EPHX2 3676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback